Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsIndustrySplitsCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Oncternal Therapeutics (ONCT) Profit Margin (2019 - 2024)

Oncternal Therapeutics (ONCT) profit margin from Jun 30, 2019 to Sep 30, 2024. The current Oncternal Therapeutics (ONCT) profit margin is -1726.53%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Oncternal Therapeutics (ONCT)

YearProfit MarginChange
2023-4997.47%
+68.58%
2022-2964.43%
+308.76%
2021-725.23%
+42.27%
2020-509.76%
-63.92%
2019-1412.81%
N/A

Comparison Oncternal Therapeutics (ONCT) profit margin with competitors

Oncternal Therapeutics (ONCT) profit margin is -1726.53%.

TickerNameProfit MarginUpside
PRTCPureTech Health plc American Depositary Shares793.00%-145.93%
ABEOAbeona Therapeutics Inc454.90%-126.35%
CHRSCoherus Biosciences Inc397.30%-123.01%
INVAInnoviva Inc119.90%-106.94%
ZVRAZevra Therapeutics Inc101.60%-105.88%
ABUSArbutus Biopharma Corp94.73%-105.49%
SAVACassava Sciences Inc.93.68%-105.43%
GLPGGalapagos NV86.83%-105.03%
CTNMContineum Therapeutics Inc - Class A83.13%-104.81%
BDTXBlack Diamond Therapeutics Inc80.77%-104.68%
NEUPNeuphoria Therapeutics Inc75.08%-104.35%
IPSCCentury Therapeutics Inc70.13%-104.06%
FULCFulcrum Therapeutics Inc69.26%-104.01%
CVACCureVac N.V.68.44%-103.96%
PRTAProthena Corporation plc64.05%-103.71%
HCWBHCW Biologics Inc63.16%-103.66%
QTTBQ32 Bio Inc61.90%-103.59%
AVIRAtea Pharmaceuticals Inc60.95%-103.53%
ASNDAscendis Pharma A/S57.30%-103.32%
PLXProtalix BioTherapeutics Inc54.27%-103.14%
AGENAgenus Inc52.20%-103.02%
CGENCompugen Ltd48.57%-102.81%
KRYSKrystal Biotech Inc48.07%-102.78%
RPRXRoyalty Pharma plc - Class A46.73%-102.71%
XOMAPXOMA Corp45.90%-102.66%
XOMAOXOMA Corp45.90%-102.66%
AUPHAurinia Pharmaceuticals Inc44.21%-102.56%
NXTCNextcure Inc43.49%-102.52%
CPRXCatalyst Pharmaceuticals Inc42.66%-102.47%
HALOHalozyme Therapeutics Inc39.83%-102.31%
ADMAAdma Biologics Inc39.59%-102.29%
XOMAXOMA Corp36.25%-102.10%
VRTXVertex Pharmaceuticals Inc34.53%-102.00%
EXELExelixis Inc34.46%-102.00%
SLNOSoleno Therapeutics Inc33.17%-101.92%
CRMDCorMedix Inc30.29%-101.75%
TNGXTango Therapeutics Inc29.52%-101.71%
ARGXArgen X SE28.20%-101.63%
CAICaris Life Sciences Inc - Class A27.98%-101.62%
JAZZJazz Pharmaceuticals plc27.42%-101.59%
SPROSpero Therapeutics Inc24.90%-101.44%
INCYIncyte Corp23.83%-101.38%
REGNRegeneron Pharmaceuticals Inc20.17%-101.17%
NAGENiagen Bioscience Inc20.07%-101.16%
ICCCImmucell Corp18.75%-101.09%
NERVMinerva Neurosciences Inc17.79%-101.03%
ALNYAlnylam Pharmaceuticals Inc16.99%-100.98%
ENVBEnveric Biosciences Inc16.64%-100.96%
TECHBio-Techne Corp16.39%-100.95%
HRMYHarmony Biosciences Holdings Inc15.08%-100.87%
RIGLRigel Pharmaceuticals14.71%-100.85%
BMRNBiomarin Pharmaceutical Inc13.77%-100.80%
VXRTVaxart Inc13.20%-100.76%
IMCRImmunocore Holdings plc12.16%-100.70%
VRNAVerona Pharma Plc11.56%-100.67%
SVASinovac Biotech Ltd11.25%-100.65%
FBIOFortress Biotech Inc10.80%-100.63%
TGTXTG Therapeutics Inc9.65%-100.56%
PHARPharming Group N.V.7.76%-100.45%
APLSApellis Pharmaceuticals Inc6.95%-100.40%
PTGXProtagonist Therapeutics Inc6.71%-100.39%
NUVBNuvation Bio Inc - Class A6.48%-100.38%
FBIOPFortress Biotech Inc6.40%-100.37%
GMABGenmab5.92%-100.34%
SRPTSarepta Therapeutics Inc2.98%-100.17%
BMEABiomea Fusion Inc2.37%-100.14%
ACADAcadia Pharmaceuticals Inc1.36%-100.08%
FENCFennec Pharmaceuticals Inc1.33%-100.08%
FOLDAmicus Therapeutics Inc0.91%-100.05%
HOTHHoth Therapeutics Inc0.17%-100.01%
BBLGBone Biologics Corp0.02%-100.00%